Physician profile
Benjamin Simpson
NPI 1225697139
$2,622.54
in general payments reported to CMS, 2019-2025
8 companies · $725 in 2025
The $725 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $87.19 · 2024: $1,811 · 2025: $725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569 · Travel and Lodging: $1,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,569.24 |
| Travel and Lodging | $1,053.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuropace, INC. | $1,562.37 | 2023-2024 | |
| Ucb, INC. | $499.08 | 2024-2025 | Fintepla, Briviact, Nayzilam |
| Abbvie INC. | $165.09 | 2025 | |
| Argenx US, INC. | $121.83 | 2024 | Vyvgart Hytrulo |
| Lundbeck LLC | $102.26 | 2024-2025 | Rexulti, Vyepti |
| Neurelis, INC. | $87.83 | 2024-2025 | Valtoco |
| Lilly USA, LLC | $55.65 | 2025 | Kisunla, Amyvid |
| Janssen Biotech, INC. | $28.43 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.